Community-acquired pneumonia.
暂无分享,去创建一个
[1] D. Musher,et al. Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia , 2016, American journal of therapeutics.
[2] E. Barrett-Connor. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. , 2015, The American review of respiratory disease.
[3] D. Musher,et al. Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics. , 2014, QJM : monthly journal of the Association of Physicians.
[4] M. Fine,et al. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. , 2014, JAMA.
[5] Á. Gentile. [U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination]. , 2014, Archivos argentinos de pediatria.
[6] T. File,et al. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. , 2013, The Journal of infectious diseases.
[7] K. Baumstarck,et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. , 2013, JAMA.
[8] J. Rello,et al. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study , 2013, Thorax.
[9] Z. Memish,et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study , 2013, The Lancet Infectious Diseases.
[10] Jian He,et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. , 2013, The New England journal of medicine.
[11] M. Kollef,et al. Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study , 2013, BMJ Open.
[12] E. Walsh,et al. Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation , 2013, The Journal of infectious diseases.
[13] D. Musher,et al. Long-term survival following pneumococcal pneumonia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] K. O'Brien,et al. Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques , 2013, PloS one.
[15] D. Musher,et al. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study , 2013, Journal of Infection.
[16] T. Wiemken,et al. Clinical scoring tools: which is best to predict clinical response and long-term outcomes? , 2013, Infectious disease clinics of North America.
[17] L. Mandell,et al. Guidelines and quality measures: do they improve outcomes of patients with community-acquired pneumonia? , 2013, Infectious disease clinics of North America.
[18] M. Postma,et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[19] T. File,et al. Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia , 2013, Current Infectious Disease Reports.
[20] W. Boersma,et al. Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia , 2013, European Respiratory Journal.
[21] John Holden,et al. Vaccines for preventing pneumococcal infection in adults. , 2013, The Cochrane database of systematic reviews.
[22] Leora I. Horwitz,et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.
[23] A. Pavia. What is the Role of Respiratory Viruses in Community-Acquired Pneumonia? , 2012, Infectious Disease Clinics of North America.
[24] J. Hedlund,et al. Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012 , 2012, Scandinavian journal of infectious diseases.
[25] D. Bratzler,et al. Predictors of in-hospital vs postdischarge mortality in pneumonia. , 2012, Chest.
[26] E. Calbo,et al. Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[27] Madhukar Pai,et al. Accuracy of Rapid Influenza Diagnostic Tests , 2012, Annals of Internal Medicine.
[28] S. Madhi,et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] M. Fine,et al. Cardiac Complications in Patients With Community-Acquired Pneumonia: Incidence, Timing, Risk Factors, and Association With Short-Term Mortality , 2012, Circulation.
[30] K. Ko,et al. Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study , 2012, Antimicrobial Agents and Chemotherapy.
[31] Carrie L. Byington,et al. FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection , 2011, PloS one.
[32] R. E. Cunningham,et al. Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak , 2011, Proceedings of the National Academy of Sciences.
[33] A. Akram,et al. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] D. Musher,et al. Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review. , 2011, The Journal of infection.
[35] J. Oosterheert,et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[36] C. Esquinas,et al. Microbial aetiology of community-acquired pneumonia and its relation to severity , 2011, Thorax.
[37] L. Gubareva,et al. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[38] T. File,et al. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] C. Frei,et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. , 2010, Clinical therapeutics.
[40] D. Musher,et al. Role of acute infection in triggering acute coronary syndromes. , 2010, The Lancet. Infectious diseases.
[41] J. Hedlund,et al. Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] J. Oosterheert,et al. Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient , 2009, Journal of General Internal Medicine.
[43] S. Fukuhara,et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis. , 2009, Chest.
[44] Liam Smeeth,et al. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. , 2009, The Lancet. Infectious diseases.
[45] W. Lim,et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.
[46] Angela H Hogan,et al. Diagnosis of Streptococcus pneumoniae Infections in Adults with Bacteremia and Community-Acquired Pneumonia: Clinical Comparison of Pneumococcal PCR and Urinary Antigen Detection , 2009, Journal of Clinical Microbiology.
[47] M. Christ-Crain,et al. Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department , 2009, BMC pulmonary medicine.
[48] J. M. Porcel,et al. Risk factors and outcome of community‐acquired pneumonia due to Gram‐negative bacilli , 2009, Respirology (Carlton South. Print).
[49] J. Fox,et al. Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia , 2008, Chest.
[50] T. Marrie,et al. Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired Pneumonia: A Population-Based Cohort Study , 2008, Medicine.
[51] J. Ramirez,et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] A. Anzueto,et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. , 2008, Chest.
[53] J. McCue,et al. Antibiotic timing and errors in diagnosing pneumonia. , 2008, Archives of internal medicine.
[54] J. Raboud,et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] D. Boulware,et al. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. , 2007, The Journal of infection.
[56] D. Moore,et al. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. , 2007, The American journal of medicine.
[57] D. Musher,et al. The association between pneumococcal pneumonia and acute cardiac events. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] V. Zarubaev,et al. Clinical Research , 2022 .
[59] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] M. Kanwar,et al. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. , 2006, Chest.
[61] M. Christ-Crain,et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.
[62] C. Weenink,et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study , 2006, BMJ : British Medical Journal.
[63] M. Bonten,et al. Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] S. Richter,et al. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] L. Alemany,et al. Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[66] D. Musher,et al. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[67] M. García-nuñez,et al. Comparative Study of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae , 2004, Scandinavian journal of infectious diseases.
[68] J. Xiang,et al. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens , 2004, Current medical research and opinion.
[69] L. Mandell,et al. Short-course treatment of community-acquired pneumonia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] T. Avšič-Županc,et al. Aetiology and Clinical Presentation of Mild Community-Acquired Bacterial Pneumonia , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[71] Jordi Carratalà,et al. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[72] W. Lim,et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.
[73] G. Royo,et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] J. Liao,et al. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[75] S. Ōmura,et al. Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. , 2000, Biochemical and biophysical research communications.
[76] M. Fine,et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. , 1997, Archives of internal medicine.
[77] M. Fine,et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia , 1997, Journal of General Internal Medicine.
[78] M. Fine,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.
[79] D. Thévenin,et al. Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score , 1996, Intensive Care Medicine.
[80] C A Britton,et al. Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. , 1996, Chest.
[81] Richard D Moore,et al. Community-acquired pneumonia: impact of immune status. , 1995 .
[82] M. Cetron,et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. , 1995, The New England journal of medicine.
[83] C. Cabellos,et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. , 1995, The New England journal of medicine.
[84] J E Heffner,et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. , 1995, American journal of respiratory and critical care medicine.
[85] T. Quinn,et al. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] J. Hermans,et al. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia , 1995, European Journal of Clinical Microbiology and Infectious Diseases.
[87] R. Austrian. Confronting Drug-resistant Pneumococci , 1994, Annals of Internal Medicine.
[88] T. Marrie. [Community acquired pneumonia]. , 1994, Praxis.
[89] V L Yu,et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .
[90] S. Sahn. Management of complicated parapneumonic effusions. , 1993, The American review of respiratory disease.
[91] V. Yu,et al. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia , 1993, The Lancet.
[92] I. Brook,et al. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. , 1993, Chest.
[93] D. Barnes. Microbial etiology of acute pneumonia in hospitalized patients. , 1993, Chest.
[94] M. Fine,et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. , 1993, The American journal of medicine.
[95] Glen A. Satten,et al. HIV Infection among Patients in U.S. Acute Care Hospitals , 1992 .
[96] G. Kinasewitz,et al. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia , 1991, European Journal of Clinical Microbiology and Infectious Diseases.
[97] M. Fisch,et al. Predicting death in patients hospitalized for community-acquired pneumonia. , 1991, Annals of internal medicine.
[98] R. Rodríguez-Roisín,et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.
[99] M. Fine,et al. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. , 1990, The American journal of medicine.
[100] M. Niederman,et al. Utility of fiberoptic bronchoscopy in nonresolving pneumonia. , 1990, Chest.
[101] W. Kapoor,et al. New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.
[102] E. Block,et al. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. , 1990, The American review of respiratory disease.
[103] D. Kaiser,et al. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. , 1989, Thorax.
[104] T. Marrie,et al. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.
[105] R. Lumb,et al. A prospective hospital study of the aetiology of community‐acquired pneumonia , 1989, The Medical journal of Australia.
[106] R. Garibaldi,et al. Epidemiology of community-acquired respiratory tract infections in adults , 1985, The American Journal of Medicine.
[107] P. Dans,et al. Management of pneumonia in the prospective payment era. A need for more clinician and support service interaction. , 1984, Archives of internal medicine.
[108] A. Esposito. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. , 1984, Archives of internal medicine.
[109] R. Larsen,et al. Diagnosis of community-acquired pneumonia: experience at a community hospital. , 1984, Comprehensive therapy.
[110] J. Bass,et al. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy , 1983, Journal of clinical microbiology.
[111] G. Warr,et al. Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia. , 1980, Infection and immunity.
[112] R. Light,et al. Cefazolin vs penicillin. Treatment of uncomplicated pneumococcal pneumonia. , 1979, JAMA.
[113] C. Helms,et al. Comparative features of pneumococcal, mycoplasmal, and Legionnaires' disease pneumonias. , 1979, Annals of internal medicine.
[114] R. Jennings,et al. Accuracy of Gram's stain in identifying pneumococci in sputum. , 1978, JAMA.
[115] D. Musher,et al. INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS , 1977, Medicine.
[116] S. Jay,et al. The radiographic resolution of Streptococcus pneumoniae pneumonia. , 1975, The New England journal of medicine.
[117] S. G. Farmer,et al. Etiologies and characteristic features of pneumonias in a municipal hospital , 1973, The American journal of the medical sciences.
[118] W. Dowdle,et al. Adult pneumonia in a general hospital. Etiology and host risk factors. , 1972, Archives of internal medicine.
[119] D. Gump,et al. Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. , 1971, The American review of respiratory disease.
[120] A. Bisno,et al. Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic , 1971, The American journal of the medical sciences.
[121] A. Wicks,et al. One-day treatment for lobar pneumonia , 1970, Thorax.
[122] P. Hoeprich. Etiologic diagnosis of lower respiratory tract infections. , 1970, California medicine.
[123] R. Chanock,et al. The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. , 1967, American journal of epidemiology.
[124] R. H. Parker,et al. Diagnostic usefulness and safety of transtracheal aspiration. , 1967, The New England journal of medicine.
[125] G. Kenny,et al. Epidemiology of Mycoplasma pneumoniae infection in families. , 1966, JAMA.
[126] E. H. Townsend,et al. Pneumococcic Segmental (Lobar) Pneumonia , 1965, Clinical pediatrics.
[127] R. Austrian,et al. THE EFFICACY OF PENICILLIN V (PHENOXYMETHYLPENICILLIN) IN THE TREATMENT OF MILD AND OF MODERATELY SEVERE PNEUMOCOCCAL PNEUMONIA , 1956, The American journal of the medical sciences.
[128] J. Bullowa,et al. The Reliability of Sputum Typing and its Relation to Serum Therapy. , 1935 .
[129] H. Svanström,et al. Cardiovascular risks with azithromycin. , 2013, The New England journal of medicine.
[130] J. Dorca,et al. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. , 2013, The Journal of infection.
[131] S. Francis,et al. Mechanistic links between acute respiratory tract infections and acute coronary syndromes. , 2013, The Journal of infection.
[132] F. Tubach,et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2013, Evidence-based child health : a Cochrane review journal.
[133] Brian A. King,et al. Current cigarette smoking among adults - United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.
[134] J. Maurer. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis , 2012 .
[135] H. Imaoka,et al. Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.
[136] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[137] R. Leggiadro. Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May–August 2009 , 2010 .
[138] R. Balk. SMART-COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community-Acquired Pneumonia , 2009 .
[139] D. Musher,et al. The History of Pneumococcal Disease , 2008 .
[140] K. Strålin. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. , 2008, International journal of antimicrobial agents.
[141] T. Marrie,et al. Etiology of community-acquired pneumonia treated in an ambulatory setting. , 2005, Respiratory medicine.
[142] M. Kolczak,et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. , 2000, The New England journal of medicine.
[143] R. Speich,et al. Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. , 1994, Journal of acquired immune deficiency syndromes.
[144] J T Macfarlane,et al. Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. , 1987, British journal of diseases of the chest.
[145] H. Reynolds,et al. Changing spectrum of pneumonia--news media creation or clinical reality? , 1983, The American journal of medicine.
[146] R. Heffron. Pneumonia, with special reference to pneumococcus lobar pneumonia , 1939 .